CAXII expression was confirmed by immunohistochemistry in a cohort of 103 breast tumor samples and associated with lower tumor grade, positive estrogen receptor (ER) status, negative EGFR status, and the absence of necrosis [8]. The gene discussed is CA12; the disease is neoplasm.